Regeneron Pharma (REGN) PT Raised to $1,250 at UBS
Tweet Send to a Friend
(Updated - July 12, 2024 11:21 AM EDT)
UBS analyst Colin Bristow raised the price target on Regeneron Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Colin Bristow raised the price target on Regeneron Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
